GRANULES.NS Cash Flow
Granules India Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹7.39 Bn | ₹4.39 Bn | ₹8.67 Bn | ₹7.93 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-1.91 Bn | ₹-3.60 Bn | ₹-6.91 Bn | ₹-7.73 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-4.40 Bn | ₹0.08 Bn | ₹-0.93 Bn | ₹3.79 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹-0.00 Bn | ₹0.03 Bn | ₹0.02 Bn | ₹0.12 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹1.07 Bn | ₹0.90 Bn | ₹0.85 Bn | ₹4.12 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹1.85 Bn | ₹2.92 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from GRANULES.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).